Company Presentation
Osasuna Therapeutics SA
| Country: | Switzerland |
| Category: | Emerging Biotech Company |
| Room: | Singapore |
| Date: | April 23, 2024 |
| Time: | 13:30 – 13:45 |
| Website: | N/A |
| Speaker: | Mark de Boer, CEO |
Company profile
Osasuna, founded in 2022, based on the work by Prof. Kroemer at Sorbonne University, Paris. Starvation of cells causes the autophagy-dependent cellular release of ACBP/DBI and and consequent feedback inhibition of autophagy. Plasma ACBP/DBI is elevated in various pathologies and neutralization of ACBP/DBI with mAbs induces autophagy, protects diverse organs against physical/chemical damage, mediates senolysis, inhibits inflammation and improves cancer immunosurveilance.
